Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference
November 08, 2018 07:00 ET
|
Capricor Therapeutics, Inc.
Research Found Exosomes Increased Exercise Capabilities and Muscle Activity in a Mouse Model of Duchenne Muscular Dystrophy LOS ANGELES, Nov. 08, 2018 (GLOBE NEWSWIRE) -- During the Action...
Capricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6
November 02, 2018 07:00 ET
|
Capricor Therapeutics, Inc.
Presentation to Focus on Company’s Therapeutic Pipeline for Duchenne Muscular Dystrophy and other Rare Diseases LOS ANGELES, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ:...